AbbVie Inc.
ABBV
$143.41
$1.020.72%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 13.93B | 13.87B | 12.23B | 15.12B | 14.81B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.93B | 13.87B | 12.23B | 15.12B | 14.81B |
| Cost of Revenue | 6.47B | 4.21B | 3.97B | 3.36B | 5.00B |
| Gross Profit | 7.46B | 9.66B | 8.25B | 11.76B | 9.81B |
| SG&A Expenses | 3.27B | 3.15B | 2.93B | 3.10B | 3.17B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -10.00M | -1.00M | -- |
| Total Operating Expenses | 11.45B | 9.09B | 9.18B | 8.25B | 9.78B |
| Operating Income | 2.47B | 4.77B | 3.04B | 6.87B | 5.03B |
| Income Before Tax | 1.95B | 2.61B | 475.00M | 2.97B | 4.40B |
| Income Tax Expenses | 172.00M | 583.00M | 234.00M | 493.00M | 448.00M |
| Earnings from Continuing Operations | 1.78B | 2.03B | 241.00M | 2.47B | 3.95B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00M | -3.00M | -2.00M | 1.00M | -3.00M |
| Net Income | 1.78B | 2.02B | 239.00M | 2.47B | 3.95B |
| EBIT | 2.47B | 4.77B | 3.04B | 6.87B | 5.03B |
| EBITDA | 4.71B | 7.03B | 5.17B | 9.03B | 7.24B |
| EPS Basic | 1.00 | 1.14 | 0.13 | 1.38 | 2.22 |
| Normalized Basic EPS | 0.74 | 1.56 | 0.90 | 2.25 | 1.61 |
| EPS Diluted | 1.00 | 1.14 | 0.13 | 1.38 | 2.21 |
| Normalized Diluted EPS | 0.73 | 1.55 | 0.90 | 2.25 | 1.61 |
| Average Basic Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.78B | 1.77B |
| Average Diluted Shares Outstanding | 1.77B | 1.77B | 1.78B | 1.78B | 1.78B |
| Dividend Per Share | 1.48 | 1.48 | 1.48 | 1.48 | 1.41 |
| Payout Ratio | 147.75% | 129.69% | 1,113.39% | 101.33% | 63.41% |
